Floatz logo

MOCLOBEMIDE

Elderly

University Hospital, ToursSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

5 Active assets in the Elderly cohort.

Asset / SponsorPhaseRating
Keppra
Nasim Tabrizi
Phase 4BB
Metformin
Fudan University
Phase 1/2CC
FILGRASTIM
The Second Hospital of Shandong University
Phase 1/2CC
Cyclophosphamide
The Second Hospital of Shandong University
Phase 1/2CC
Sertraline
University Hospital, Tours
N/AD

View all 11 →

Same molecule, other indications

MOCLOBEMIDE is also rated in:

physiological malfunction arising from mental factorDormant
B
Indicative ·
57 / 100
View asset →
anxiety disorderDormant
B
Indicative ·
57 / 100
View asset →
dementiaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →